Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02686359Completed
Single-blind trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Opiorphin levels in saliva at Day 30. Started Jul 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02686359.